Clinical Trial Update: Long-Term Use Of Pegaptanib In Patients For Subfoveal Choroidal Neovascularization Secondary To Age-Related Macular Degeneration

View source ↗

Summary

This entry notes a completed clinical trial evaluating the long-term use of pegaptanib for subfoveal choroidal neovascularization due to age-related macular deg…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• Macugen (pegaptanib sodium)

Snippet

Sponsor: Pfizer | Conditions: Macular Degeneration | Status: COMPLETED